Japan’s Taisho Pharmaceutical Holdings has completed the acquisition of a 24.4 per cent stake in Vietnam-listed DHG Pharma JSC, while 34 of the latter’s overseas shareholders exited the company, according to a disclosure by the Vietnam Securities Depository.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
